XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
Jul. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Debt      
Common stock, par value   $ 0.0001 $ 0.0001
K2 HealthVentures LLC | Maximum      
Debt      
Investment from lenders in future equity financings $ 5,000    
Percent of equity investment from lenders 10.00%    
Term loan | K2 HealthVentures LLC      
Debt      
Principal amount $ 50,000    
Interest rate (as a percent) 7.95%    
Interest only payments term 30 months    
Period of interest and principal payments 18 months    
Threshold interest rate 3.20%    
End of term charge (as a percent) 6.45%    
Effective interest rate 11.19%    
Principal amount for debt conversion $ 3,250    
Common stock, par value $ 0.0001    
Conversion price $ 2.6493    
Nasdaq beneficial ownership limitations, percentage 19.99%    
Debt issuance costs $ 900    
Interest expense   $ 589  
Term loan | K2 HealthVentures LLC | Repayment in first year after funding      
Debt      
Percent of prepayment premium 3.00%    
Term loan | K2 HealthVentures LLC | Repayment in second year after funding      
Debt      
Percent of prepayment premium 2.00%    
Term loan | K2 HealthVentures LLC | Repayment in third year after funding      
Debt      
Percent of prepayment premium 1.00%    
Term loan | K2 HealthVentures LLC | Repayment after third year of funding      
Debt      
Percent of prepayment premium 0.00%    
Term loan | K2 HealthVentures LLC | Minimum      
Debt      
Cash, cash equivalents and marketable securities balances to be maintained $ 25,000    
Term loan | K2 HealthVentures LLC | Maximum      
Debt      
Total market capitalization 250,000    
Term loan tranche one | K2 HealthVentures LLC      
Debt      
Principal amount 30,000    
Term loan tranche two | K2 HealthVentures LLC      
Debt      
Principal amount $ 20,000